Person profile
Address
San Francisco, California
Employees
Former names
Graham Dawn
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Adverum Biotechnologies, Inc.
20 Jun 24
4
ACELYRIN, Inc.
11 Jun 24
4
Xenon Pharmaceuticals Inc.
5 Jun 24
4
Xenon Pharmaceuticals Inc.
24 Aug 23
144
Xenon Pharmaceuticals Inc.
24 Aug 23
4
Adverum Biotechnologies, Inc.
13 Jun 23
4
Xenon Pharmaceuticals Inc.
2 Jun 23
4
ACELYRIN, Inc.
11 May 23
4
ACELYRIN, Inc.
4 May 23
3
ACELYRIN, Inc.
4 May 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jun 24 | ADVM Adverum Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 7.32 | 10,520 | 77.01 k | 10,520 |
7 Jun 24 | SLRN Acelyrin | Director Stock Option Common Stock | Grant | Acquire A | No | No | 4.46 | 92,158 | 411.02 k | 92,158 |
5 Jun 24 | XENE Xenon Pharmaceuticals | Stock Option Common Shares | Grant | Acquire A | No | No | 38.16 | 15,542 | 593.08 k | 15,542 |
24 Aug 23 | XENE Xenon Pharmaceuticals | Common Shares | Sell | Dispose S | No | No | 38.7 | 25,000 | 967.50 k | 25,000 |
9 Jun 23 | ADVM Adverum Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 1.56 | 40,000 | 62.40 k | 40,000 |